alzheimer
New Alzheimer’s Drug Slows Early Stages Of Disease
A new study revealed that Lilly Biotechnology Center’s Alzheimer’s drug slowed the disease by as much as 22% to 35%, compared to a separate placebo study.
A new study revealed that Lilly Biotechnology Center’s Alzheimer’s drug slowed the disease by as much as 22% to 35%, compared to a separate placebo study.
Former First Lady Rosalynn Carter has been diagnosed with dementia according to the Carter Center which made the announcement on Tuesday.